PD-1 ligands are seldom expressed on DLBCL cell lines in-vitro but have been demonstrated on malignant B-cells and TAMs in vivo suggesting PD-L1/2 expression is driven largely by tumor extrinsic, rather than intrinsic mechanisms [125]. This evidence concerns the gene PDCD1 and neoplasm.